Content Type: Research Publications

Medicare Spending and Use of Subcutaneous Biologic Formulations with Hyaluronidase

March 6, 2026

Disappearing Data at the U.S. Federal Government

March 6, 2026

Examining Pricing and Availability for Neglected Tropical Disease Therapies in the United States

March 6, 2026

The Strength and Importance of Government-Funded Patents for Approved Drugs

March 6, 2026

Frequency and Nature of Generic “Design Around” of Brand‐name Patents in the United States

March 6, 2026

Evolving Recommendations for Patient Populations Among Oncology Medicines: A Quantitative and Qualitative Analysis

March 6, 2026

Design Patents: A Potential Threat to Drug Competition

March 6, 2026

Data Manipulation Within the US Federal Government

March 6, 2026

Costs of Extending the Small Molecule Exemption Period in Medicare Drug Price Negotiation

March 6, 2026

The Comparative Effectiveness and Safety of Fluticasone-Salmeterol Via Metered-Dose Versus Dry Powder Inhalers for COPD: A New User Cohort Study

March 6, 2026

Use and Cost of First-Line Biologic Medications to Treat Plaque Psoriasis in the US

March 6, 2026

Predictors of Withdrawal of Anticancer Drug Indications Granted Accelerated Approval: a Retrospective Cohort Study

March 6, 2026